$4.97 Billion is the total value of PFM Health Sciences, LP's 61 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | New | BRISTOL MYERS SQUIBB CO | $400,326,000 | – | 7,532,007 | +100.0% | 8.05% | – |
| GOOGL | New | GOOGLE INCcl a | $262,794,000 | – | 234,489 | +100.0% | 5.28% | – |
| B108PS | New | ACTAVIS PLC | $199,254,000 | – | 1,186,035 | +100.0% | 4.00% | – |
| VLO | New | VALERO ENERGY CORP NEW | $119,998,000 | – | 2,380,911 | +100.0% | 2.41% | – |
| TSO | New | TESORO CORP | $117,305,000 | – | 2,005,206 | +100.0% | 2.36% | – |
| FB | New | FACEBOOK INCcl a | $111,338,000 | – | 2,037,334 | +100.0% | 2.24% | – |
| CCI | New | CROWN CASTLE INTL CORP | $103,674,000 | – | 1,411,872 | +100.0% | 2.08% | – |
| ENDP | New | ENDO HEALTH SOLUTIONS INC | $79,534,000 | – | 1,178,973 | +100.0% | 1.60% | – |
| CME | New | CME GROUP INC | $71,026,000 | – | 905,252 | +100.0% | 1.43% | – |
| COG | New | CABOT OIL & GAS CORP | $67,737,000 | – | 1,747,597 | +100.0% | 1.36% | – |
| MPC | New | MARATHON PETE CORP | $54,990,000 | – | 599,472 | +100.0% | 1.10% | – |
| MHFI | New | MCGRAW HILL FINL INC | $52,118,000 | – | 666,475 | +100.0% | 1.05% | – |
| AGN | New | ALLERGAN INC | $50,092,000 | – | 450,950 | +100.0% | 1.01% | – |
| WDAY | New | WORKDAY INCcl a | $35,325,000 | – | 424,785 | +100.0% | 0.71% | – |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $19,785,000 | – | 889,520 | +100.0% | 0.40% | – |
| ANAC | New | ANACOR PHARMACEUTICALS INC | $17,703,000 | – | 1,055,014 | +100.0% | 0.36% | – |
| New | OREXIGEN THERAPEUTICS INCnote 2.750%12/0 | $12,406,000 | – | 12,635,000 | +100.0% | 0.25% | – | |
| ILMN | New | ILLUMINA INC | $10,404,000 | – | 94,079 | +100.0% | 0.21% | – |
| RLYP | New | RELYPSA INC | $8,038,000 | – | 321,527 | +100.0% | 0.16% | – |
| SCAI | New | SURGICAL CARE AFFILIATES INC | $7,538,000 | – | 216,360 | +100.0% | 0.15% | – |
| OCR | New | OMNICARE INC | $7,450,000 | – | 123,428 | +100.0% | 0.15% | – |
| DNDNQ | New | DENDREON CORP | $6,003,000 | – | 2,007,813 | +100.0% | 0.12% | – |
| BMY | New | BRISTOL MYERS SQUIBB COcall | $2,884,000 | – | 2,045,500 | +100.0% | 0.06% | – |
| MGNX | New | MACROGENICS INC | $2,327,000 | – | 84,846 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2014-02-21
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
| HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
| HUMANA INC | 37 | Q3 2023 | 3.8% |
| EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
| UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
| PENUMBRA INC | 33 | Q3 2023 | 4.8% |
| AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
| TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
| ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
| Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
| Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Erasca, Inc. | February 14, 2023 | ? | ? |
| Generation Bio Co. | February 14, 2023 | ? | ? |
| IO Biotech, Inc. | February 14, 2023 | ? | ? |
| Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Outset Medical, Inc. | February 14, 2023 | ? | ? |
| uniQure N.V. | February 14, 2023 | ? | ? |
| AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.